✦ LIBER ✦

Gastroschisis: a national cohort study to describe contemporary surgical strategies and outcomes

✍ Scribed by Anthony Owen; Sean Marven; Paul Johnson; Jennifer Kurinczuk; Patsy Spark; Elizabeth S. Draper; Peter Brocklehurst; Marian Knight

Book ID: 116688340
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 311 KB
Volume: 45
Category: Article
ISSN: 0022-3468
DOI: 10.1016/j.jpedsurg.2010.01.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Comparison of Surgical Approaches for

A Comparison of Surgical Approaches for Primary Hip Arthroplasty: A Cohort Study of Patient Reported Outcome Measures (PROMs) and Early Revision Using Linked National Databases

✍ Jameson, Simon S.; Mason, James; Baker, Paul; Gregg, Paul J.; McMurtry, Ian A.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 467 KB

Surgical outcomes and patient perception

Surgical outcomes and patient perceptions following mastectomy with or without reconstruction: a study to inform the national mastectomy & breast reconstruction audit

✍ Sue Down; J. Pereira 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Short and Long-Term Mortality After Appe

Short and Long-Term Mortality After Appendectomy in Sweden 1987 to 2006. Influence of Appendectomy Diagnosis, Sex, Age, Co-morbidity, Surgical Method, Hospital Volume, and Time Period. A National Population-Based Cohort Study

✍ Roland E. Andersson 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 154 KB

Outcomes after switching from one anti–t

Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study

✍ Kimme L. Hyrich; Mark Lunt; Kath D. Watson; Deborah P. M. Symmons; Alan J. Silma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) who experience treatment failure with one anti–tumor necrosis factor (anti‐TNF) agent, due to either inefficacy or toxicity, are frequently switched to a second anti‐TNF agent, although the benefits of switching are unknown. The pres